A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

Published:2010-06 Issue:5 Volume:32 Page:451-459
ISSN:0161-6412
Container-title:Neurological Research
language:en
Short-container-title:Neurological Research

Author:

Collin C.,Ehler E.,Waberzinek G.,Alsindi Z.,Davies P.,Powell K.,Notcutt W.,O'Leary C.,Ratcliffe S.,Nováková I.,Zapletalova O.,Piková J.,Ambler Z.

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1179/016164109X12590518685660

Reference31 articles.

1. Prevalence and treatment of spasticity reported by multiple sclerosis patients

2. Regional variations in the prevalence of multiple sclerosis in French farmers

3. High-dose oral baclofen: Experience in patients with multiple sclerosis

4. Pharmacology of cannabinoid CB1 and CB2 receptors

5. Neuropharmacology and therapeutic potential of cannabinoids

Cited by 238 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, double-blind, placebo-controlled trial to evaluate the effect of nabiximols oromucosal spray on clinical measures of spasticity in patients with multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-09

2. Cannabiskonsum und Cannabiskonsumstörungen;Der Nervenarzt;2024-08-12

3. The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex^® - A Cannabis-derived Spray;Mini-Reviews in Medicinal Chemistry;2024-08

4. GPCR kinase subtype requirements for arrestin-2 and -3 translocation to the cannabinoid CB1 receptor and the consequences on G protein signalling;Biochemical Pharmacology;2024-06

5. Effectiveness, Safety and Patients’ Satisfaction of Nabiximols (Sativex®) on Multiple Sclerosis Spasticity and Related Symptoms in a Swiss Multicenter Study;Journal of Clinical Medicine;2024-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3